SEC Form 4 · accession 0001193125-26-274545
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D. Yee
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 17, 2026 · 7:24 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001544227
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.27 | Jun 4, 2026 | A | 25,000 | A | — | Jun 4, 2036 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The shares subject to each such stock option will vest over a three-year period, with one-third of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service.
Remarks
This transaction is being reported late due to an inadvertent administrative oversight.